BNTXBioNTech SEvs its industry peers
A metric-by-metric comparison of BioNTech SE against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BNTX본 종목 | $22.8B#13 | — | — | — | — | — | — | — | — | — | -13.5%#10 | — |
| VRTX | $139.2B#4 | 35.3x#4 | 6.7x#4 | 11.6x#7 | 8.9%#8 | 838.1%#3 | 34.8%#2 | 18.9%#5 | 17.4%#6 | — | 30.3%#8 | — |
| AMGN | $258.6B#2 | 27.7x#3 | 18.0x#9 | 7.0x#4 | 10.0%#7 | 88.5%#7 | 24.7%#7 | 53.7%#2 | 14.2%#7 | — | 64.1%#6 | 2.0%#1 |
| GILD | $216.4B#3 | — | 16.6x#7 | 7.3x#5 | 2.4%#9 | 1672.9%#2 | 34.0%#3 | 65.3%#1 | 25.7%#3 | — | 44.4%#7 | 1.9%#2 |
| REGN | — | 20.6x#2 | — | — | 1.0%#11 | 2.1%#10 | 24.9%#6 | 13.4%#6 | 9.2%#9 | — | — | — |
| ARGX | $57.6B#6 | — | — | 1621.8x#12 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 12.0%#9 | — |
| ALNY | $21.6B#14 | 8.4x#1 | 6.0x#3 | 5.8x#3 | 65.2%#3 | 212.8%#4 | 13.5%#9 | 8.7%#8 | 19.3%#5 | — | -62.0%#11 | — |
| NTRA | $56.3B#7 | — | 30.9x#10 | 24.4x#8 | 35.9%#5 | -9.3%#11 | -13.4%#11 | -11.4%#10 | -18.0%#10 | — | 99.1%#3 | — |
| RVMD | $43.2B#8 | — | 18.0x#8 | — | — | -88.5%#14 | — | -47.1%#12 | — | — | 240.8%#2 | — |
| BIIB | $37.6B#9 | 110.2x#7 | 2.5x#1 | 3.8x#1 | 2.2%#10 | -20.8%#12 | 28.7%#5 | 8.7%#7 | 12.3%#8 | 3#3 | 70.7%#5 | — |
| ILMN | $34.3B#10 | 39.0x#5 | 10.9x#5 | 7.9x#6 | -0.7%#12 | 169.5%#5 | 18.6%#8 | 27.0%#3 | 19.9%#4 | 8#1 | 93.9%#4 | — |
| MRNA | $103.2B#5 | — | 15.3x#6 | 53.1x#10 | -39.9%#13 | 20.8%#9 | -158.1%#12 | -41.7%#11 | -54.6%#11 | — | 988.4%#1 | — |
| INSM | $24.1B#12 | — | 33.2x#11 | 39.8x#9 | 66.7%#2 | -39.7%#13 | -205.6%#13 | -175.8%#13 | -141.2%#12 | 3#3 | — | — |
| ONC | $558.0B#1 | 877.9x#8 | 107.8x#12 | 104.4x#11 | 40.2%#4 | 144.5%#6 | 8.4%#10 | 5.5%#9 | 29.9%#2 | 6#2 | — | — |
| INCY | $25.1B#11 | 62.7x#6 | 4.4x#2 | 4.9x#2 | 21.2%#6 | 3846.9%#1 | 29.5%#4 | 22.8%#4 | 45.1%#1 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-05.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice